CS-747S PhaseIII trial
Phase 3
- Conditions
- Subject with acute coronary syndromes who are to undergo percutaneous coronary intervention (PCI)
- Registration Number
- JPRN-jRCT2080221302
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Are 20 or above when informed consent is written.
-Have recent acute coronary syndrome defined as a recent history of ischemic symptoms at rest associated with ECG changes consistent with ischemia and/or elevated cardiac enzymes, and are scheduled for PCI.
Exclusion Criteria
-High bleeding risk
-Subjects who have severe complication to be treated (e.g. refractory arrhythmia, malignancy)
-hepatic disease or renal disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method